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Background: We serially evaluated vascular response to new generation everolimus-eluting stent (EES) and biolimus A9-eluting biodegradable 
polymer stent (BES) in comparison with sirolimus-eluting stent (SES) by optical coherence tomography (OCT). 
Methods: 6 stent each were implanted in coronary arteries of 6 miniature swine and assessed by OCT subsequently at 1-month and 6-month. In 
every 1mm cross section, neointimal thickness (NIT), neointimal uneveness score (NUS) and % uncovered strut were measured. At 1-month, the ratio 
of OCT intensity of neointimal tissue (It) and intensity of strut (Is) were measured, and histopathology analysis was done at 6-month.  
Results: At 1-month, EES showed highest NIT and the lowest %uncovered strut and NUS compared with BES and SES. It/Is was lowest in SES. At 
6-month, NIT, NUS and %uncovered strut were equivocal, whileΔNIT was lowest in EES (Table). ΔNIT was correlated with 6-month inflammation score 
(r=0.523, P<0.001). 
Conclusions: SES revealed uneven tissue coverage with different light properties at 1-months, leading to overshoot neointimal proliferation and 
persistent inflammation at 6-month. On the other hand, EES seems to have most pro-healing advantage.
EES BES SES P value
1-month OCT NIT(μm) 269±98 198±103 102±63 0.006
NUS 1.4±0.1 2.5±1.3 3.2±1.5 0.01
%uncover 0.4±0.8 24.5±23.8 41.7±27.0 0.004
It/Is 0.75±0.06 0.75±0.06 0.73±0.08 0.002
6-month OCT NIT(μm) 572±219 603±73 616±68 0.86
NUS 1.4±0.2 1.3±0.1 1.3±0.1 0.30
%uncover 0 0 0 1.00
ΔNIT (NIT 6mo - NIT 1mo) 303±140 404±50 514±55 0.002
6-month Histo Inflammation score 0.39±0.6 0.28±0.29 1.63±1.53 0.04
